Literature DB >> 30505471

A paradigm shift in the treatment of mild asthma?

Wei Tang1, Lin Sun1, J Mark FizGerald2.   

Abstract

Entities:  

Year:  2018        PMID： 30505471      PMCID： PMC6236170          DOI： 10.21037/jtd.2018.09.127

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  14 in total

1.  Association between prescribing patterns of anti-asthmatic drugs and clinically uncontrolled asthma: a cross-sectional study.

Authors:  Jesper Rømhild Davidsen; Jesper Hallas; Jens Søndergaard; René Depont Christensen; Hans Christian Siersted; Malene Plejdrup Hansen; Thomas Bøllingtoft Knudsen; Jesper Lykkegaard; Morten Andersen
Journal:  Pulm Pharmacol Ther       Date:  2011-09-17       Impact factor: 3.410

2.  Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study.

Authors:  K F Rabe; P A Vermeire; J B Soriano; W C Maier
Journal:  Eur Respir J       Date:  2000-11       Impact factor: 16.671

Review 3.  Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis.

Authors:  Diana M Sobieraj; Erin R Weeda; Elaine Nguyen; Craig I Coleman; C Michael White; Stephen C Lazarus; Kathryn V Blake; Jason E Lang; William L Baker
Journal:  JAMA       Date:  2018-04-10       Impact factor: 56.272

4.  "Global strategy for asthma management and prevention: GINA executive summary." E.D. Bateman, S.S. Hurd, P.J. Barnes, J. Bousquet, J.M. Drazen, J.M. FitzGerald, P. Gibson, K. Ohta, P. O'Byrne, S.E. Pedersen, E. Pizzichini, S.D. Sullivan, S.E. Wenzel and H.J. Zar. Eur Respir J 2008; 31: 143-178.

Authors: 
Journal:  Eur Respir J       Date:  2018-01-31       Impact factor: 16.671

5.  Direct health care costs associated with asthma in British Columbia.

Authors:  Mohsen Sadatsafavi; Larry Lynd; Carlo Marra; Bruce Carleton; Wan C Tan; Sean Sullivan; J Mark Fitzgerald
Journal:  Can Respir J       Date:  2010 Mar-Apr       Impact factor: 2.409

6.  Dispensation of long-acting β agonists with or without inhaled corticosteroids, and risk of asthma-related hospitalisation: a population-based study.

Authors:  Mohsen Sadatsafavi; Larry D Lynd; Carlo A Marra; J Mark FitzGerald
Journal:  Thorax       Date:  2013-11-26       Impact factor: 9.139

7.  Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma.

Authors:  Paul M O'Byrne; J Mark FitzGerald; Eric D Bateman; Peter J Barnes; Nanshan Zhong; Christina Keen; Carin Jorup; Rosa Lamarca; Stefan Ivanov; Helen K Reddel
Journal:  N Engl J Med       Date:  2018-05-17       Impact factor: 91.245

Review 8.  The paradoxes of asthma management: time for a new approach?

Authors:  Paul M O'Byrne; Christine Jenkins; Eric D Bateman
Journal:  Eur Respir J       Date:  2017-09-09       Impact factor: 16.671

9.  Measurement of asthma control according to Global Initiative for Asthma guidelines: a comparison with the Asthma Control Questionnaire.

Authors:  José María Olaguibel; Santiago Quirce; Berta Juliá; Cristina Fernández; Ana María Fortuna; Jesús Molina; Vicente Plaza
Journal:  Respir Res       Date:  2012-06-22

10.  Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey.

Authors:  David Price; Monica Fletcher; Thys van der Molen
Journal:  NPJ Prim Care Respir Med       Date:  2014-06-12       Impact factor: 2.871
View more
  1 in total

1.  Asthma, from mild to severe, is an independent prognostic factor for mild to severe Coronavirus disease 2019 (COVID-19).

Authors:  Wang Chun Kwok; Anthony Raymond Tam; James Chung Man Ho; David Chi Leung Lam; Terence Chi Chun Tam; King Pui Florence Chan; Julie Kwan Ling Wang; Mary Sau Man Ip; Ivan Fan Ngai Hung
Journal:  Clin Respir J       Date:  2022-02-11       Impact factor: 1.761
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.